Dr. Soojin Jang & David Shum have been invited to a session with DNDi to discuss potential collaboration on GARD – Global Antibiotic Research & Development project.  It's mission is to develop new antibiotic treatments through combinatorial drug screening & promote the responsible use of antibiotics, while ensuring equitable access for all in need. Currently antibiotic resistance is a global issue. IPK’s Antibac Resistance Research Lab focuses on the discovery of novel antibacterial agents & Assay Development & Screening Group utilizes HTS technology for early drug discovery.

 
+Hyperlink to DNDi GARD section: http://www.dndi.org/diseases-projects/gard/
+Hyperlink to WHO’s GARD section: http://www.who.int/phi/implementation/consultation_imnadp/en/
+Hyperlink to Antibacterial Resistance Research Laboratory(ARRL), IPK: http://www.ip-korea.org/RDP/ARRL.php
+Hyperlink to Assay Development & Screening Group(ADS), IPK: http://www.ip-korea.org/RDP/ADS.php